Close Menu

Selventa

Selventa Raises $5M

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Life science data analysis firm Selventa has raised $5 million in an equity round, it disclosed in a document filed with the US Securities and Exchange Commission this week.

Selventa said this week that it has partnered with Linguamatics to add natural language processing-based text-mining capability to its knowledge-extraction and discovery platform.

Selventa CEO David de Graaf has been selected to serve on the scientific advisory board of the Massachusetts Institute of Technology's Center for Cancer Systems Biology.

The Swiss Institute of Bioinformatics has tapped Selventa's CEO David de Graaf and Alexey Nesvizhskii, an assistant professor at the University of Michigan, Ann Arbor, to serve on its scientific advisory board.

Movers & Shakers: Aug 19, 2011

Premium

The Swiss Institute of Bioinformatics has appointed David de Graaf and Alexey Nesvizhskii to serve on its scientific advisory board.

Luis Serrano, James Collins, Mathukumalli Vidyasagar, Joel Saltz

Pfizer and Selventa plan to create a publicly available version of Selventa's Biological Expression Language and associated BEL Framework that will enable groups to capture, store, combine, and use scientific knowledge to inform decision-making for drug targets.

John Tagliamonte

Pages

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.